ArticleClinical Medicine Insights. Cardiology2026
Spatial Metabolic Profiling of Human Atrial Tissue in Atrial Fibrillation Using DESI-MSI: An Exploratory Pilot Study.
Article in Clinical Medicine Insights. Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Structural remodeling and atrial fibrosis are hallmarks of atrial fibrillation (AF), yet molecular alterations associated with atrial remodeling remain incompletely characterized, particularly their spatial distribution within human atrial tissue. Desorption Electrospray Ionization Mass Spectrometry Imaging (DESI-MSI) enables spatially resolved metabolic profiling of tissue sections and may provide insight into metabolic alterations associated with atrial remodeling in AF. This study investigated whether DESI-MSI could identify distinct metabolic signatures in atrial tissue from patients with AF. Methods: In this exploratory pilot study, atrial tissue samples from 10 patients undergoing cardiac surgery (4 with AF and 6 controls) underwent DESI-MSI analysis across an m/z range of 50-1200, followed by histologic assessment with hematoxylin-eosin staining. Metabolic profiles were analyzed using principal component analysis (PCA) and linear discriminant analysis (LDA) to explore group-specific metabolic patterns. Results: Histologic evaluation demonstrated minimal fibrosis without significant differences between AF and control samples. In contrast, DESI-MSI identified distinct metabolic features associated with AF. Arachidonic acid (m/z 303.2) and phosphatidylinositol species (m/z 885.5) demonstrated spatial correspondence with myocardial architecture and contributed to metabolic separation between groups. Exploratory supervised multivariate analysis showed partial separation between AF and control spectra, while LD loading plots identified differential lipid-related ion patterns associated with AF samples. Conclusions: In this exploratory pilot cohort, DESI-MSI demonstrated preliminary metabolic differences between AF and control atrial tissues despite limited histologic remodeling. These findings should be considered hypothesis-generating and will require validation in larger, adequately matched cohorts integrating metabolic, histologic, and clinical phenotypes. Although they do not establish that metabolic remodeling precedes fibrosis, they raise the possibility that DESI-MSI may detect metabolic differences in atrial tissue exhibiting minimal histologic remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.